Atlas Trials

Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

Clinical trial NCT00086983 · TERMINATED

Trial details

NCT number
NCT00086983
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2004-05-01
Primary completion
2006-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.